Integrated Serum Metabolomics and Network Pharmacology Approach to Reveal the Potential Mechanisms of Diwuyanggan Prescription in the Prevention of Acute Liver Injury

被引:1
作者
Xu, Jinlin [1 ]
Zou, Feng [2 ]
Lin, Yuqi [1 ]
Zeng, Zhaoxiang [1 ]
Liu, Yukun [1 ]
Zhang, Lijun [2 ]
Huang, Rongzeng [1 ]
Li, Xugui [3 ]
Song, Chengwu [1 ]
Tang, Yinping [1 ,4 ]
Jin, Shuna [2 ,5 ]
机构
[1] Hubei Univ Chinese Med, Coll Pharm, Wuhan, Peoples R China
[2] Hubei Univ Chinese Med, Coll Basic Med, Wuhan, Peoples R China
[3] Hubei 672 Orthopaed Hosp Integrated Chinese & West, Wuhan, Peoples R China
[4] Hubei Univ Chinese Med, Coll Pharm, 16Huangjiahu West Rd, Wuhan 430065, Peoples R China
[5] Hubei Univ Chinese Med, Coll Basic Med, 16 Huangjiahu West Rd, Wuhan 430065, Peoples R China
关键词
Diwuyanggan; acute liver injury; metabolomics; network pharmacology; LC-MS; MS; CHOLESTERYL ESTER HYDROLASE; THIOACETAMIDE; RATS; INFLAMMATION; ACID; REGENERATION; HEPATITIS; PROTECTS; CURCUMIN; STRESS;
D O I
10.1177/1934578X231180076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Acute liver injury (ALI) has become a major reason for emergency liver transplantation mortality worldwide. Diwuyanggan (DWYG), a hospital preparation of traditional chinese medicine, does a satisfactory job of treating liver disease, but its pharmacological mechanisms should be further investigated. Thus, we aimed to unravel the mechanisms of DWYG against ALI through a comprehensive approach integrating metabolomics and network pharmacology analysis in this study. Methods: An untargeted metabolomics based on ultra-high pressure liquid chromatography together with quadrupole time of flight mass spectrometry was applied to identify differential metabolites between normal mice and thioacetamide (TAA)-induced ALI mice. By utilizing network pharmacology, potential targets against ALI caused by TAA were excavated. Subsequently, the key targets were validated by real-time polymerase chain reaction assays. Results: DWYG alleviated TAA-induced ALI. Furthermore, 28 differential metabolites were identified with an association between ALI pathological processes and DWYG effects. The pathways involved in bile acid, glycerophospholipid, fatty acid, sphingolipid, tryptophan, and tyrosine metabolism. Then, we found 127 active compounds in DWYG and 26 hub genes associated with the treatment of ALI according to network pharmacology. Besides, according to Kyoto Encyclopedia of Genes and Genome analysis, sphingolipid signaling pathway was deemed as one of the main signaling pathways involved in DWYG anti-ALI, which was in agreement with the metabolomics findings. Further, a combined analysis was performed focusing on 7 key targets, including mitogen-activated protein kinase 1, mitogen-activated protein kinase 8, caspase 3, peroxisome proliferator-activated receptor gamma, albumin, carboxylesterase 1 and glucocerebrosidase, along with their related core metabolites and pathways. Confirmatory experiment further showed that DWYG could reverse the abnormal mRNA expression of these targets in TAA mice. Conclusion: This study revealed direct evidence for the preventive effect of DWYG against ALI and the related pharmacological mechanisms.
引用
收藏
页数:17
相关论文
共 65 条
  • [1] Metabolomics study of early metabolic changes in hepatic HepaRG cells in response to rosemary diterpenes exposure
    Acunha, Tanize
    Garcia-Canas, Virginia
    Valdes, Alberto
    Cifuentes, Alejandro
    Simo, Carolina
    [J]. ANALYTICA CHIMICA ACTA, 2018, 1037 : 140 - 151
  • [2] Acute liver failure
    Bernal, William
    Auzinger, Georg
    Dhawan, Anil
    Wendon, Julia
    [J]. LANCET, 2010, 376 (9736) : 190 - 201
  • [3] Network-based Approaches in Pharmacology
    Boezio, Baptiste
    Audouze, Karine
    Ducrot, Pierre
    Taboureau, Olivier
    [J]. MOLECULAR INFORMATICS, 2017, 36 (10)
  • [4] ERKS - A FAMILY OF PROTEIN-SERINE THREONINE KINASES THAT ARE ACTIVATED AND TYROSINE PHOSPHORYLATED IN RESPONSE TO INSULIN AND NGF
    BOULTON, TG
    NYE, SH
    ROBBINS, DJ
    IP, NY
    RADZIEJEWSKA, E
    MORGENBESSER, SD
    DEPINHO, RA
    PANAYOTATOS, N
    COBB, MH
    YANCOPOULOS, GD
    [J]. CELL, 1991, 65 (04) : 663 - 675
  • [5] Cajone F, 1984, Toxicol Pathol, V12, P74
  • [6] Ceramides - Lipotoxic Inducers of Metabolic Disorders
    Chaurasia, Bhagirath
    Summers, Scott A.
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (10) : 538 - 550
  • [7] Chen G., 2021, CHIN J INTEGR TRADIT, V31, P668
  • [8] Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ
    Chen, Qingshan
    Bao, Leilei
    Lv, Lei
    Xie, Fangyuan
    Zhou, Xuwei
    Zhang, Hai
    Zhang, Guoqing
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (19)
  • [9] Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic degradation
    Chen, Wenjia
    Ma, Zhaochen
    Yu, Lingxiang
    Mao, Xia
    Ma, Nan
    Guo, Xiaodong
    Yin, Xiaoli
    Jiang, Funeng
    Wang, Qian
    Wang, Jigang
    Fang, Mingliang
    Lin, Na
    Zhang, Yanqiong
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2022, 54 (09) : 1536 - 1548
  • [10] CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid
    Cheng, Jie
    Krausz, Kristopher W.
    Li, Feng
    Ma, Xiaochao
    Gonzalez, Frank J.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 266 (02) : 245 - 253